Latest Streamline Health Solutions (STRM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Streamline Health Solutions (STRM) Headlines

Norman Regional Renews contract for business analytics solutions With Streamline Health
PR Newswire - Mon Mar 03, 8:00AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions that help healthcare providers reduce exposure to risk, enhance clinical, financial and operational performance and improve patient care, today announced Norman Regional Health System, a client of Streamline Health for the last five years, has renewed its contract for Streamline Health's suite of business analytics solutions as well as its Solution Optimization Services.

Streamline Health® Strengthens Its Executive Team
PR Newswire - Wed Feb 26, 3:00PM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions that help healthcare providers reduce exposure to risk, enhance clinical, financial and operational performance and improve patient care today announced several executive management enhancements. Richard Nelli, formerly Streamline's Chief Technology Officer, has been named Senior Vice President and Chief Operating Officer to reflect the expansion of the responsibilities of his role at the company. In addition, Streamline Health has named Randy Salisbury as Senior Vice President and Chief Marketing Officer. Both gentlemen will report directly to Robert E. Watson, President and Chief Executive Officer, Streamline Health.

Cymetrix Enters Into Strategic Relationship With Streamline Health To Use Its Technology For Outsourced HIM Services
PR Newswire - Tue Feb 25, 8:00AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare organizations, today announced that Cymetrix, a national leader in providing comprehensive revenue cycle management solutions, has signed a five-year agreement to use Streamline Health's software solutions. Streamline Health's ECM, CAC and CDI solutions will significantly expand Cymetrix's health information management (HIM) capabilities including coding and clinical documentation improvement services.

Streamline Health® Completes Acquisition of Unibased Systems Architecture, Inc.
PR Newswire - Tue Feb 04, 8:00AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today confirmed the completion of the previously announced acquisition of St. Louis-based Unibased Systems Architecture, Inc. (Unibased) on February 3, 2014.

Streamline Health Solutions (STRM) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 7:35AM CST
The shares of Streamline Health Solutions, Inc. fell over 6% on the day. This continues the most recent downtrend for STRM, as the stock is down 17% since Jan 13.

Streamline Health Solutions Shares Down 15.5% Since SmarTrend's Sell Call (STRM)
Comtex SmarTrend(R) - Wed Jan 29, 11:16AM CST
SmarTrend identified a Downtrend for Streamline Health Solutions (NASDAQ:STRM) on November 18th, 2013 at $7.06. In approximately 2 months, Streamline Health Solutions has returned 15.45% as of today's recent price of $5.97.

Parkview Health Extends Client Partnership with Streamline Health® via New Three-Year Agreement for Additional Business Analytics Solutions
PR Newswire - Wed Jan 22, 8:00AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced a new contract with existing client Parkview Health to add business analytics and denials management to the client's current suite of Streamline Health solutions. These additions will enable Parkview to improve their current reporting and analytical capabilities across the revenue cycle while consolidating the multitude of solutions currently used to gather the information required to run the business. By implementing the business analytics and denial management solutions from Streamline Health, Parkview can significantly expedite existing processes and improve the consistency of accessing critical data and information required to maximize both financial and operational performance.

Streamline Health® Signs Definitive Agreement To Acquire Unibased Systems Architecture, Inc.
PR Newswire - Thu Jan 16, 3:14PM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced the company has signed a definitive agreement to acquire St. Louis-based Unibased Systems Architecture, Inc. (Unibased), a leading provider of patient access solutions. Unibased provides health information technology solutions including enterprise scheduling and surgery management software for leading healthcare organizations throughout the United States. The closing of the acquisition, expected to occur in early February 2014, is subject to the satisfaction of various customary closing conditions, including approval by Unibased's stockholders.

Streamline Health Solutions, Inc. Reports $6.7 Million Revenue; $0.6 Million Adjusted EBITDA in Q3 2013
PR Newswire - Thu Dec 12, 3:00PM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced financial results for the third quarter of fiscal year 2013, which ended October 31, 2013.

Streamline Health® To Announce Third Quarter Financial Results December 12, 2013
PR Newswire - Tue Dec 03, 5:24PM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced that it will release its third quarter 2013 financial results for the period ended October 31, 2013 on December 12, 2013. The Company will conduct a conference call and webcast to review the results on Thursday, December 12, 2013 at 5:00 p.m. EST.

Streamline Health® Expands Client Partnership with Children's National Medical Center
PR Newswire - Mon Dec 02, 8:00AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced that client Children's National Medical Center will deploy OpportunityAnyWare, the company's business analytics software suite. Additionally, Children's National's community-based pediatric network will implement key components of the suite, which include the ARWare(TM) and DenialWare(TM) solutions.

Streamline Health® Announces Pricing Of Upsized Public Offering Of Common Stock
PR Newswire - Fri Nov 22, 6:00AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced that it has priced a public offering of 3,000,000 shares of its common stock to be sold by the Company at a price to the public of $6.50 per share. The offering was upsized from the previously announced public offering of 2,500,000 shares of common stock. The Company granted the underwriters a 30-day option to purchase up to an additional 450,000 shares to cover over-allotments, if any. Subject to customary conditions, the offering is expected to close on or about November 27, 2013.

Streamline Health(R) Announces Public Offering of Common Stock to Fund Proposed Acquisitions and Reduce Debt
Business Wire - Thu Nov 14, 3:44PM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers, today announced that it intends to offer 2,500,000 shares of its common stock, par value $0.01 per share, in an underwritten public offering, subject to market and other conditions. In addition, Streamline Health intends to grant the underwriters a 30-day option to purchase up to 375,000 additional shares of Streamline Health common stock to cover over-allotments, if any. There can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Streamline Health(R) Announces Intent To Acquire Two Companies
Business Wire - Thu Nov 14, 3:44PM CST
--Company Provides Preliminary Financial Results for Q3 and Guidance for Fiscal Years 2013 and 2014

Streamline Health Solutions Shares Up 17.1% Since SmarTrend's Buy Recommendation (STRM)
Comtex SmarTrend(R) - Thu Nov 14, 11:16AM CST
SmarTrend identified an Uptrend for Streamline Health Solutions (NASDAQ:STRM) on July 2nd, 2013 at $6.70. In approximately 5 months, Streamline Health Solutions has returned 17.10% as of today's recent price of $7.84.

Uptrend Call Working As Streamline Health Solutions Stock Rises 20.1% (STRM)
Comtex SmarTrend(R) - Thu Nov 07, 9:59AM CST
SmarTrend identified an Uptrend for Streamline Health Solutions (NASDAQ:STRM) on July 2nd, 2013 at $6.70. In approximately 4 months, Streamline Health Solutions has returned 20.09% as of today's recent price of $8.04.

Streamline Health Solutions Up 17.1% Since SmarTrend Uptrend Call (STRM)
Comtex SmarTrend(R) - Thu Oct 31, 9:29AM CDT
SmarTrend identified an Uptrend for Streamline Health Solutions (NASDAQ:STRM) on July 2nd, 2013 at $6.70. In approximately 4 months, Streamline Health Solutions has returned 17.10% as of today's recent price of $7.84.

Streamline Health(R) and Montefiore Medical Center Announce Agreement to Commercialize Clinical Analytics Platform
Business Wire - Tue Oct 29, 8:03AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM) and Montefiore Medical Center today announced an exclusive 15-year licensing agreement enabling Streamline Health to commercialize Montefiore's unique clinical analytics platform, successfully in use at Montefiore since 2002. Through this agreement, Streamline Health will acquire from Montefiore the existing contract with the Bronx RHIO, a Health Information Exchange (HIE) that uses the analytics platform to enable providers throughout the borough to securely query and analyze patient information. The platform, in conjunction with Bronx RHIO's HIE platform, allows healthcare providers to assemble all of the clinical data available within their system from disparate sources, including lab results, ambulatory encounters and prior visits, and draw actionable conclusions on demand to improve patient care and safety.

Uptrend Call Working As Streamline Health Solutions Stock Rises 19.6% (STRM)
Comtex SmarTrend(R) - Wed Oct 23, 5:13PM CDT
SmarTrend identified an Uptrend for Streamline Health Solutions (NASDAQ:STRM) on July 2nd, 2013 at $6.70. In approximately 4 months, Streamline Health Solutions has returned 19.64% as of today's recent price of $8.01.

Streamline Health Solutions Has Returned 17.6% Since SmarTrend Recommendation (STRM)
Comtex SmarTrend(R) - Wed Oct 16, 11:15AM CDT
SmarTrend identified an Uptrend for Streamline Health Solutions (NASDAQ:STRM) on July 2nd, 2013 at $6.70. In approximately 4 months, Streamline Health Solutions has returned 17.55% as of today's recent price of $7.87.

Streamline Health Solutions Inc. (STRM) Stock Research Links

STRM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading